Aurobindo gets Australian nod for cholesterol pills

11 May 2009

1

Drug maker Aurobindo Pharma today said it had received Australian regulatory approval for registration of Simvastatin tablets, used in the treatment of high cholesterol.

In a filing to the Bombay Stock Exchange, the company said its wholly-owned subsidiary Aurobindo Pharma Australia Pty Ltd has received approval from Australia's Therapeutic Goods Administration for the registration.

Simvastatin is a common prescription medication used in the treatment of high cholesterol. The drug also decreases the chance of developing cardiovascular diseases. The tablets are in the strength of 5, 10, 20, 40 and 80 mg.

Earlier in March, the company had received two TGA approvals for its Lisinopril and Sertraline tablets. This is the third approval received by the company from TGA, Australia, it said.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more